IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹969 Cr | ₹1,014 Cr | ₹902 Cr | ₹614 Cr | ₹190 Cr |
What is the latest Total Non-Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹969 Cr |
| Mar2024 | ₹1,014 Cr |
| Mar2023 | ₹902 Cr |
| Mar2022 | ₹614 Cr |
| Mar2021 | ₹190 Cr |
How is Total Non-Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹969 Cr | -4.46 | |
| Mar2024 | ₹1,014 Cr | 12.50 | |
| Mar2023 | ₹902 Cr | 46.89 | |
| Mar2022 | ₹614 Cr | 223.62 | |
| Mar2021 | ₹190 Cr | - | |
Compare Total Non-Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹44,949.3 Cr | 2.5% | 6.9% | 30.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 2.5% |
6.9% |
30.7% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses